Nifty

:

14677.80

Sensex

:

48732.55

-18.70 (-0.13%)
41.75 (0.09%)

Login

Nifty
Sensex

:
:

14677.80
48732.55

-18.70 (-0.13%)
41.75 (0.09%)

Venus Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

63/99

BSE: 526953 | NSE: VENUSREM

Watchlist

NSE BSE

312.45

14-May-2021

Open
High
Low
Previous Close

315.50
328.85
308.15
315.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

49318
156.65
353.75
43.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

385.56
18.12
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

603.89
N/A
1.10

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.61
-3.98
-2.85

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-7.61
-12.84
0.67

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-31.19

P:E (Median)

8 Years
5 Years
3 Years

5.07
9.32
-

P:BV (Average)

8 Years
5 Years
3 Years

0.36
0.26
0.27

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.10
7.09
8.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 114.07 92.23 23.68% 118.41 80.08 47.86% 179.71 70.82 153.76% 79.22 86.37 -8.28%
Expenses 101.03 80.27 25.86% 113.25 65.55 72.77% 158.91 60.66 161.97% 72.82 83.47 -12.76%
EBITDA 13.04 11.96 9.03% 5.16 14.53 -64.49% 20.80 10.17 104.52% 6.41 2.90 121.03%
EBIDTM 11.43% 12.97% 4.36% 18.15% 11.57% 14.36% 8.09% 3.35%
Other Income 1.15 1.61 -28.57% 11.74 0.73 1,508.22% 1.51 0.42 259.52% 2.70 3.80 -28.95%
Interest 1.73 4.00 -56.75% 7.33 4.91 49.29% 2.79 6.01 -53.58% 0.00 0.00 0
Depreciation 8.42 8.23 2.31% 8.35 8.34 0.12% 8.33 8.26 0.85% 6.22 8.25 -24.61%
PBT 8.50 1.33 539.10% 8.82 2.02 336.63% 2.01 -3.69 - -5.93 -10.52 -
Tax 2.21 0.99 123.23% 1.49 0.16 831.25% 0.00 0.00 0 0.82 -0.10 -
PAT 6.29 0.35 1,697.14% 7.33 1.86 294.09% 2.01 -3.69 - -6.74 -10.42 -
PATM 5.52% 0.38% 6.19% 2.32% 1.12% -5.21% -8.51% -12.06%
EPS 5.12 0.28 1,728.57% 5.96 1.51 294.70% 1.63 -3.00 - -5.48 -8.47 -

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 121.94 96.86 25.89% 126.07 87.89 43.44% 188.75 73.65 156.28% 83.06 90.44 -8.16%
Expenses 103.86 86.06 20.68% 115.42 75.19 53.50% 173.19 63.86 171.20% 75.53 88.89 -15.03%
EBITDA 18.08 10.79 67.56% 10.65 12.71 -16.21% 15.55 9.78 59.00% 7.53 1.56 382.69%
EBIDTM 14.83% 11.14% 8.45% 14.46% 8.24% 13.28% 9.07% 1.72%
Other Income 1.83 1.77 3.39% 12.28 1.35 809.63% 2.04 0.82 148.78% 3.18 4.29 -25.87%
Interest 1.81 4.07 -55.53% 7.39 4.91 50.51% 2.85 6.18 -53.88% 0.00 0.00 0
Depreciation 8.70 8.48 2.59% 8.61 8.56 0.58% 3.59 8.50 -57.76% 6.47 8.46 -23.52%
PBT 13.86 0.02 69,200.00% 14.52 0.58 2,403.45% 1.97 -4.07 - -4.56 -11.57 -
Tax 2.21 0.99 123.23% 1.49 0.16 831.25% 0.00 0.00 0 0.82 -0.10 -
PAT 11.65 -0.96 - 13.03 0.42 3,002.38% 1.97 -4.07 - -5.38 -11.46 -
PATM 9.56% -0.99% 10.33% 0.47% 1.05% -5.53% -6.48% -12.68%
EPS 9.44 -0.78 - 10.55 0.34 3,002.94% 1.60 -3.30 - -4.36 -9.29 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 491.41 322.36 301.84 355.07 375.45 402.69 451.88 526.06 461.34 405.19 356.68 Net Sales Growth 49.14% 6.80% -14.99% -5.43% -6.76% -10.89% -14.10% 14.03% 13.86% 13.60% Cost Of Goods Sold 308.68 176.81 181.78 205.42 186.69 194.64 213.05 298.96 263.27 226.04 199.89 Gross Profit 182.73 145.55 120.06 149.65 188.76 208.05 238.82 227.10 198.07 179.15 156.80 GP Margin 37.18% 45.15% 39.78% 42.15% 50.28% 51.67% 52.85% 43.17% 42.93% 44.21% 43.96% Total Expenditure 446.01 279.29 267.55 311.51 328.16 323.14 364.94 392.83 342.85 299.29 265.60 Power & Fuel Cost - 3.41 3.50 3.02 3.08 2.90 3.28 3.11 2.86 2.49 2.28 % Of Sales - 1.06% 1.16% 0.85% 0.82% 0.72% 0.73% 0.59% 0.62% 0.61% 0.64% Employee Cost - 33.79 30.26 27.82 25.02 25.02 27.26 25.57 23.24 20.58 17.30 % Of Sales - 10.48% 10.03% 7.84% 6.66% 6.21% 6.03% 4.86% 5.04% 5.08% 4.85% Manufacturing Exp. - 18.35 18.98 34.28 75.01 58.94 73.60 20.75 19.72 17.45 16.47 % Of Sales - 5.69% 6.29% 9.65% 19.98% 14.64% 16.29% 3.94% 4.27% 4.31% 4.62% General & Admin Exp. - 15.22 9.79 11.86 12.20 10.85 14.36 13.81 11.10 11.34 10.75 % Of Sales - 4.72% 3.24% 3.34% 3.25% 2.69% 3.18% 2.63% 2.41% 2.80% 3.01% Selling & Distn. Exp. - 31.72 23.24 29.11 26.17 30.78 33.39 30.64 22.66 21.18 18.92 % Of Sales - 9.84% 7.70% 8.20% 6.97% 7.64% 7.39% 5.82% 4.91% 5.23% 5.30% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 18.92 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0.05% 0% EBITDA 45.41 43.07 34.29 43.56 47.29 79.55 86.94 133.23 118.49 105.90 91.08 EBITDA Margin 9.24% 13.36% 11.36% 12.27% 12.60% 19.75% 19.24% 25.33% 25.68% 26.14% 25.54% Other Income 17.10 3.58 4.51 1.19 3.10 0.67 0.55 0.41 0.39 0.38 0.29 Interest 11.85 13.05 25.15 35.44 35.87 36.74 40.70 29.29 24.45 27.26 18.71 Depreciation 31.32 31.05 32.95 32.73 39.32 40.47 44.74 38.61 31.76 23.86 17.91 PBT 13.40 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 55.15 54.76 Tax 4.52 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 5.12 7.28 Tax Rate 33.73% -31.31% 4.07% -13.49% 18.39% 60.13% -123.04% 7.27% 8.82% 9.28% 13.29% PAT 8.89 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 50.03 47.48 PAT before Minority Interest 8.89 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 50.03 47.48 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.81% -2.55% -8.98% -7.49% -5.39% 0.30% 1.01% 11.59% 12.39% 12.35% 13.31% PAT Growth 174.71% - - - - -73.63% -92.53% 6.65% 14.23% 5.37% EPS 7.23 -6.69 -22.04 -21.61 -16.46 0.98 3.70 49.55 46.46 40.67 38.60

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 519.82 341.46 321.89 372.41 400.04 418.27 463.99 541.56 468.64 409.84 363.09 Net Sales Growth 49.01% 6.08% -13.57% -6.91% -4.36% -9.85% -14.32% 15.56% 14.35% 12.88% Cost Of Goods Sold 299.82 174.31 181.95 205.08 227.07 238.51 268.94 300.00 262.26 225.91 201.50 Gross Profit 220.00 167.15 139.94 167.33 172.97 179.77 195.05 241.55 206.38 183.92 161.59 GP Margin 42.32% 48.95% 43.47% 44.93% 43.24% 42.98% 42.04% 44.60% 44.04% 44.88% 44.50% Total Expenditure 468.00 300.64 289.37 332.94 349.32 337.11 374.81 403.33 348.53 306.96 273.00 Power & Fuel Cost - 4.73 4.86 4.29 4.14 4.01 3.80 3.38 3.05 2.71 2.72 % Of Sales - 1.39% 1.51% 1.15% 1.03% 0.96% 0.82% 0.62% 0.65% 0.66% 0.75% Employee Cost - 46.02 42.10 39.31 34.27 32.44 32.36 30.45 27.30 24.83 20.38 % Of Sales - 13.48% 13.08% 10.56% 8.57% 7.76% 6.97% 5.62% 5.83% 6.06% 5.61% Manufacturing Exp. - 20.84 21.01 36.10 42.48 15.70 17.29 22.10 20.61 18.18 17.05 % Of Sales - 6.10% 6.53% 9.69% 10.62% 3.75% 3.73% 4.08% 4.40% 4.44% 4.70% General & Admin Exp. - 17.57 11.85 13.52 13.26 11.97 15.67 14.74 11.82 12.14 11.54 % Of Sales - 5.15% 3.68% 3.63% 3.31% 2.86% 3.38% 2.72% 2.52% 2.96% 3.18% Selling & Distn. Exp. - 37.18 27.60 34.65 28.10 34.48 36.75 32.65 23.50 22.98 19.82 % Of Sales - 10.89% 8.57% 9.30% 7.02% 8.24% 7.92% 6.03% 5.01% 5.61% 5.46% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 19.82 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0.05% 0% EBITDA 51.81 40.82 32.52 39.47 50.72 81.16 89.18 138.23 120.11 102.88 90.09 EBITDA Margin 9.97% 11.95% 10.10% 10.60% 12.68% 19.40% 19.22% 25.52% 25.63% 25.10% 24.81% Other Income 19.33 5.31 6.09 2.39 4.28 2.01 0.68 0.47 0.44 0.49 0.40 Interest 12.05 13.34 25.41 35.56 36.38 37.98 41.21 29.40 24.63 27.49 18.86 Depreciation 27.37 32.01 33.98 33.83 40.26 41.68 46.00 40.22 33.08 25.02 18.98 PBT 25.79 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 50.85 52.63 Tax 4.52 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 3.78 6.41 Tax Rate 17.53% -24.41% 3.87% -11.48% 21.07% 51.57% -94.72% 6.92% 8.80% 7.43% 12.18% PAT 21.27 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 47.08 46.22 PAT before Minority Interest 21.27 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 47.08 46.22 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.09% -2.93% -8.88% -8.24% -4.27% 0.41% 1.11% 11.87% 12.23% 11.49% 12.73% PAT Growth 232.36% - - - - -67.05% -91.98% 12.20% 21.73% 1.86% EPS 17.29 -8.13 -23.23 -24.95 -13.89 1.38 4.20 52.28 46.59 38.28 37.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 332.25 340.95 367.99 394.23 444.43 466.24 467.42 392.24 319.11 246.59 Share Capital 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 9.74 9.13 Total Reserves 319.91 328.61 355.65 381.89 432.99 454.79 455.97 376.92 300.35 233.27 Non-Current Liabilities 96.03 136.75 157.89 179.52 212.03 221.50 161.27 147.18 113.50 99.41 Secured Loans 23.92 60.88 86.02 112.69 134.55 150.91 114.28 103.89 75.45 65.97 Unsecured Loans 48.34 55.20 50.84 49.13 56.47 51.34 25.22 25.22 23.68 22.02 Long Term Provisions 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 2.50 1.94 Current Liabilities 209.93 254.46 222.61 193.71 177.59 157.06 207.33 190.06 154.13 124.69 Trade Payables 33.96 33.41 27.19 30.56 23.90 25.76 28.14 17.87 12.33 6.11 Other Current Liabilities 93.94 107.61 76.87 45.70 36.63 13.99 54.12 57.88 43.22 40.27 Short Term Borrowings 81.42 108.92 117.23 115.70 115.09 115.40 110.08 95.68 83.24 63.17 Short Term Provisions 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 15.33 15.14 Total Liabilities 638.21 732.16 748.49 767.46 834.05 844.80 836.02 729.48 586.74 470.69 Net Block 271.47 346.89 369.93 389.38 433.52 425.77 416.09 380.92 335.86 274.04 Gross Block 589.77 674.06 669.01 655.78 660.61 612.50 555.61 481.83 405.01 319.32 Accumulated Depreciation 318.30 327.17 299.08 266.40 227.09 186.73 139.52 100.91 69.15 45.28 Non Current Assets 360.33 478.57 499.96 517.54 575.53 618.72 567.61 500.20 413.61 331.63 Capital Work in Progress 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 23.00 15.31 Non Current Investment 0.14 0.14 0.14 28.74 28.74 28.74 28.74 28.74 28.74 28.37 Long Term Loans & Adv. 64.08 66.78 65.13 33.17 32.90 85.91 54.98 42.74 26.01 13.91 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 277.89 253.59 248.53 249.93 258.53 226.08 268.41 229.28 173.13 139.07 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 136.44 140.94 135.98 139.69 137.69 140.44 141.46 126.40 96.19 75.43 Sundry Debtors 29.78 31.39 44.15 41.91 53.88 59.37 62.80 53.11 44.33 36.41 Cash & Bank 1.44 1.28 3.64 3.15 3.04 3.52 4.38 6.26 2.91 2.91 Other Current Assets 110.23 5.15 4.84 0.00 63.91 22.76 59.77 43.51 29.70 24.31 Short Term Loans & Adv. 54.51 74.83 59.93 65.18 63.91 22.76 59.77 43.51 29.70 24.11 Net Current Assets 67.96 -0.87 25.93 56.22 80.94 69.02 61.08 39.21 19.00 14.38 Total Assets 638.22 732.16 748.49 767.47 834.06 844.80 836.02 729.48 586.74 470.70

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 323.37 332.52 361.91 388.67 437.62 456.68 461.61 379.13 307.29 236.92 Share Capital 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 9.74 9.13 Total Reserves 311.03 320.18 349.57 376.33 426.18 445.24 450.17 363.81 288.53 223.59 Non-Current Liabilities 95.82 136.68 158.47 179.52 212.05 221.55 161.75 147.18 113.51 99.41 Secured Loans 24.19 61.29 86.60 112.69 134.57 150.95 114.76 103.89 75.45 65.97 Unsecured Loans 47.87 54.73 50.84 49.13 56.47 51.34 25.22 25.22 23.68 22.02 Long Term Provisions 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 2.50 1.94 Current Liabilities 218.53 263.62 230.38 196.81 193.14 162.83 210.99 191.25 153.22 124.53 Trade Payables 36.70 36.00 29.33 29.73 25.14 29.56 31.22 18.76 12.55 7.02 Other Current Liabilities 95.65 110.30 78.47 46.16 42.71 15.96 54.70 58.18 43.44 40.07 Short Term Borrowings 85.58 112.80 121.26 119.16 123.32 115.40 110.08 95.68 83.24 63.17 Short Term Provisions 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 13.99 14.27 Total Liabilities 637.72 732.82 750.76 765.00 842.81 841.06 834.35 717.56 574.02 460.86 Net Block 289.37 364.45 389.20 406.18 452.48 443.65 439.46 401.42 355.39 293.28 Gross Block 623.96 707.02 702.77 686.50 679.57 641.12 587.38 511.00 430.25 343.15 Accumulated Depreciation 334.59 342.57 313.57 280.32 227.09 197.47 147.93 109.58 74.87 49.86 Non Current Assets 349.77 467.39 490.50 505.60 565.75 607.85 562.24 491.97 404.40 322.49 Capital Work in Progress 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 23.00 15.31 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 35.77 38.18 36.53 33.17 32.90 85.91 54.98 42.74 26.01 13.91 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 287.95 265.43 260.27 259.41 277.07 233.21 272.11 225.58 169.63 138.37 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 141.12 142.73 138.17 140.60 143.29 142.87 142.26 128.03 96.82 75.43 Sundry Debtors 30.69 38.04 47.27 47.29 61.59 63.22 64.99 47.11 40.10 35.74 Cash & Bank 2.13 2.81 3.98 3.56 7.07 3.62 4.41 6.36 2.95 3.12 Other Current Assets 114.01 5.15 4.84 0.00 65.12 23.51 60.47 44.08 29.77 24.07 Short Term Loans & Adv. 58.29 76.70 66.00 67.96 65.12 23.51 60.47 44.08 29.77 23.87 Net Current Assets 69.43 1.81 29.88 62.59 83.93 70.38 61.12 34.33 16.41 13.84 Total Assets 637.72 732.82 750.77 765.01 842.82 841.06 834.35 717.55 574.03 460.86

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 77.15 43.65 51.58 61.77 41.91 66.76 52.56 50.66 38.06 39.34 PBT 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 55.15 54.76 Adjustment 40.39 59.20 64.73 69.30 53.72 81.90 35.95 39.38 27.76 23.16 Changes in Working Capital 19.78 3.75 10.27 17.27 -14.82 -17.18 -49.12 -51.39 -44.85 -38.58 Cash after chg. in Working capital 62.71 43.65 51.58 61.77 41.91 66.76 52.56 50.66 38.06 39.34 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.64 -11.27 -11.48 -18.06 3.20 -67.15 -93.75 -102.47 -93.63 -98.23 Net Fixed Assets 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 -93.38 -94.69 Net Investments 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 -0.37 -3.58 Others -129.06 -6.22 -28.34 -37.01 53.38 0.24 0.02 -0.84 0.12 0.04 Cash from Financing Activity -72.35 -34.74 -39.61 -43.60 -45.59 -0.47 39.31 55.15 55.57 59.80 Net Cash Inflow / Outflow 0.16 -2.36 0.49 0.11 -0.48 -0.86 -1.88 3.35 0.00 0.91 Opening Cash & Equivalents 1.28 3.64 3.15 3.04 3.52 4.38 6.26 2.91 2.91 2.00 Closing Cash & Equivalent 1.44 1.28 3.64 3.15 3.04 3.52 4.38 6.26 2.91 2.91

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 77.01 45.33 31.19 58.93 46.88 67.80 52.65 52.15 41.67 37.35 PBT 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 50.85 52.63 Adjustment 41.56 60.72 66.24 70.61 56.41 83.56 37.21 40.72 29.96 24.74 Changes in Working Capital 20.23 5.37 -7.52 9.96 -13.04 -18.40 -53.65 -51.41 -39.14 -40.02 Cash after chg. in Working capital 62.57 45.33 31.19 58.93 46.88 67.80 52.65 52.15 41.67 37.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -4.75 -11.33 -11.48 -18.32 2.92 -67.18 -94.66 -103.89 -95.15 -96.43 Net Fixed Assets 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 -93.38 -94.69 Net Investments 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 -0.37 -3.58 Others -129.17 -6.28 -28.34 -37.27 53.10 0.21 -0.89 -2.26 -1.40 1.84 Cash from Financing Activity -73.00 -35.17 -39.23 -44.13 -46.35 -1.42 40.06 55.15 53.31 59.80 Net Cash Inflow / Outflow -0.74 -1.17 -19.52 -3.51 3.46 -0.79 -1.95 3.41 -0.17 0.72 Opening Cash & Equivalents 2.81 3.98 0.00 7.07 3.62 4.41 6.36 2.95 3.12 2.40 Closing Cash & Equivalent 2.13 2.81 -19.52 3.56 7.07 3.62 4.41 6.36 2.95 3.12

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 269.21 276.25 298.16 319.42 388.42 407.48 408.51 367.54 318.30 265.52 ROA -1.20% -3.66% -3.51% -2.53% 0.14% 0.54% 7.79% 8.68% 9.46% 11.44% ROE -2.44% -7.65% -6.98% -4.83% 0.26% 0.97% 14.26% 16.38% 18.11% 22.65% ROCE 1.15% -0.48% 1.75% 1.50% 5.11% 5.55% 13.40% 14.49% 16.94% 19.29% Fixed Asset Turnover 0.51 0.45 0.54 0.57 0.63 0.77 1.02 1.04 1.12 1.28 Receivable days 34.63 45.68 44.23 46.56 51.33 49.34 40.15 38.45 36.30 34.91 Inventory Days 157.03 167.43 141.69 134.83 126.05 113.85 92.77 87.83 77.16 70.17 Payable days 42.18 37.63 31.43 27.90 25.33 24.89 20.07 14.84 10.66 8.22 Cash Conversion Cycle 149.48 175.48 154.49 153.50 152.04 138.30 112.85 111.44 102.80 96.86 Total Debt/Equity 0.65 0.86 0.82 0.78 0.74 0.68 0.62 0.70 0.71 0.77 Interest Cover 0.52 -0.12 0.34 0.31 1.08 1.05 3.24 3.56 3.02 3.93

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 262.01 269.42 293.23 314.92 382.47 399.13 403.43 355.10 306.18 254.92 ROA -1.46% -3.85% -4.05% -2.12% 0.20% 0.62% 8.29% 8.87% 9.10% 11.40% ROE -3.05% -8.23% -8.18% -4.13% 0.38% 1.12% 15.38% 17.04% 17.73% 23.07% ROCE 0.90% -0.67% 1.17% 2.00% 5.35% 5.74% 14.06% 14.85% 16.47% 19.24% Fixed Asset Turnover 0.51 0.46 0.54 0.59 0.63 0.76 0.99 1.00 1.06 1.20 Receivable days 36.73 48.37 46.34 49.67 54.45 50.42 37.72 33.88 33.71 32.14 Inventory Days 151.71 159.26 136.61 129.51 124.86 112.15 90.94 87.34 76.56 68.94 Payable days 42.53 37.91 30.30 26.74 26.74 27.25 21.28 15.09 11.03 8.63 Cash Conversion Cycle 145.91 169.72 152.65 152.44 152.57 135.32 107.37 106.14 99.25 92.44 Total Debt/Equity 0.68 0.90 0.85 0.80 0.77 0.70 0.63 0.72 0.74 0.80 Interest Cover 0.40 -0.17 0.23 0.41 1.09 1.06 3.35 3.55 2.85 3.79

Top Investors:

guttikonda vara lakshmi

rajasekhar guttikonda

Annual Reports:

News Update:

Venus Remedies partners with West Pharmaceutical Services to launch Cloti-Xa in India
13th Apr 2021, 13:33 PM

Cloti-Xa which contains enoxaparin sodium is being introduced with added advantage of NovaGuard SA Pro safety system
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback